Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

Why are physicians reluctant to use estrogens for anything--or do they prefer 'PROFOX'?

Studd J.

Menopause Int. 2009 Jun;15(2):52-4. doi: 10.1258/mi.2009.009019.

PMID:
19465668
2.

'PROFOX'--the post HRT nightmare.

Studd J.

Climacteric. 2011 Apr;14(2):217-9. doi: 10.3109/13697137.2010.529199. Epub 2010 Nov 25. Review.

PMID:
21105839
3.

Estrogens as first-choice therapy for osteoporosis prevention and treatment in women under 60.

Studd J.

Climacteric. 2009 Jun;12(3):206-9. doi: 10.1080/13697130902721873.

PMID:
19437196
4.

Osteoporosis management in a Medicaid population after the Women's Health Initiative study.

Lee E, Wutoh AK, Xue Z, Hillman JJ, Zuckerman IH.

J Womens Health (Larchmt). 2006 Mar;15(2):155-61.

PMID:
16536679
5.

Why are physicians reluctant to use estrogens for anything: or do they prefer 'PROFOX'?

Bowring C, Reid D, Francis R.

Menopause Int. 2009 Sep;15(3):99; author's reply 99. doi: 10.1258/mi.2009.009034. No abstract available.

PMID:
19723678
6.

Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.

Kang BM, Kim MR, Park HM, Yoon BK, Lee BS, Chung HW, Cho SH, Choi H, Kim JG.

Menopause. 2006 Jan-Feb;13(1):125-9.

PMID:
16607108
7.

Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy.

Richman S, Edusa V, Fadiel A, Naftolin F.

Menopause. 2006 Jan-Feb;13(1):148-55.

PMID:
16607111
8.

Patients' and clinicians' attitudes after the Women's Health Initiative study.

Blümel JE, Castelo-Branco C, Chedraui PA, Binfa L, Dowlani B, Gómez MS, Sarrá S.

Menopause. 2004 Jan-Feb;11(1):57-61.

PMID:
14716183
9.

Transdermal hormone therapy and bone health.

Shulman LP.

Clin Interv Aging. 2008;3(1):51-4. Review.

10.

Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society.

North American Menopause Society.

Menopause. 2006 May-Jun;13(3):340-67; quiz 368-9.

PMID:
16735931
11.

The attitude of gynecologists in São Paulo, Brazil 3 years after the Women's Health Initiative study.

Lazar F Jr, Costa-Paiva L, Morais SS, Pedro AO, Pinto-Neto AM.

Maturitas. 2007 Feb 20;56(2):129-41. Epub 2006 Aug 8.

PMID:
16901660
12.

Ten reasons to be happy about hormone replacement therapy: a guide for patients.

Studd J.

Menopause Int. 2010 Mar;16(1):44-6. doi: 10.1258/mi.2010.010001.

PMID:
20424287
13.
14.

Estrogen therapy for geriatric osteoporosis: just one ball in a complex juggling act.

Hillner BE.

South Med J. 1992 Aug;85(8):2S10-6. Review.

PMID:
1502606
15.

Effect of microdose transdermal 17beta-estradiol compared with raloxifene in the prevention of bone loss in healthy postmenopausal women: a 2-year, randomized, double-blind trial.

Schaefers M, Muysers C, Alexandersen P, Christiansen C.

Menopause. 2009 May-Jun;16(3):559-65. doi: 10.1097/gme.0b013e31818ebfba.

PMID:
19423999
16.

Women's awareness and knowledge of hormone therapy post-Women's Health Initiative.

Rigby AJ, Ma J, Stafford RS.

Menopause. 2007 Sep-Oct;14(5):853-8.

PMID:
17429334
17.

Postmenopausal osteoporosis and hormone replacement therapy.

Gambacciani M, Vacca F.

Minerva Med. 2004 Dec;95(6):507-20. Review. English, Italian.

PMID:
15785435
18.

Depression and the menopause: why antidepressants are not enough?

Graziottin A, Serafini A.

Menopause Int. 2009 Jun;15(2):76-81. doi: 10.1258/mi.2009.009021. Review.

PMID:
19465674
19.

[Hormone substitution in the female climacteric--goals, means, effects].

Hauser GA.

Ther Umsch. 1990 Dec;47(12):970-84. Review. German.

PMID:
2096481
20.

Treatment of menopausal symptoms in family medicine settings following the Women's Health Initiative findings.

Burg MA, Fraser K, Gui S, Grant K, Kosch SG, Nierenberg B, Oyama O, Pomm H, Sibille K, Spruill T, Swartz V; Florida Behavioral Health Research Consortium.

J Am Board Fam Med. 2006 Mar-Apr;19(2):122-31.

Supplemental Content

Support Center